Cited by 27

The DOI matches its Crossref record.

Oligomerization of the E5 protein of human papillomavirus type 16 occurs through multiple hydrophobic regions

Gieswein, Christine E, Sharom, Frances J, Wildeman, Alan G·2003·Virology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0042-6822(03)00296-4

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 51

  1. Adam, 2000, A mutagenic analysis of the E5 protein of human papillomavirus type 16 reveals that E5 binding to the vacuolar H+-ATPase is not sufficient for biological activity, using mammalian and yeast expression systems, Virology, 272, 315, 10.1006/viro.2000.0376 · DOI
  2. Adduci, 1999, The transmembrane domain of the E5 oncoprotein contains functionally discrete helical faces, J. Biol. Chem., 274, 10249, 10.1074/jbc.274.15.10249 · DOI
  3. Andresson, 1995, Vacuolar H+-ATPase mutants transform cells and define a binding site for the papillomavirus E5 oncoprotein, J. Biol. Chem., 270, 6830, 10.1074/jbc.270.12.6830 · DOI
  4. Ashrafi, 2000, Binding of bovine papillomavirus type 4 E8 to ductin (16K proteolipid), down-regulation of gap junction intercellular communication and full cell transformation are independent events, J. Gen. Virol., 81, 689, 10.1099/0022-1317-81-3-689 · DOI
  5. Bryan, 1998, The intracellular expression pattern of the human papillomavirus type 11 E1Ê4 protein correlates with its ability to self associate, Virology, 241, 49, 10.1006/viro.1997.8965 · DOI
  6. Bubb, 1988, DNA sequence of the HPV-16 E5 ORF and the structural conservation of its encoded protein, Virology, 163, 243, 10.1016/0042-6822(88)90259-0 · DOI
  7. Burkhardt, 1987, Genetic and biochemical definition of the bovine papillomavirus E5 transforming protein, EMBO J., 6, 2381, 10.1002/j.1460-2075.1987.tb02515.x · DOI
  8. Burkhardt, 1989, The E5 oncoprotein of bovine papillomavirus is oriented asymmetrically in Golgi and plasma membranes, Virology, 170, 334, 10.1016/0042-6822(89)90391-7 · DOI
  9. Chen, 1996, Mutational analysis of human papillomavirus type 11 E5a oncoprotein, J. Virol., 70, 3502, 10.1128/jvi.70.6.3502-3508.1996 · DOI
  10. Chen, 1994, E5a gene of human papillomavirus type 11 is required for initiation but not for maintenance of transformation in NIH 3T3 cells, J. Gen. Virol., 75, 1953, 10.1099/0022-1317-75-8-1953 · DOI
  11. Conrad, 1993, The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein, J. Virol., 67, 6170, 10.1128/jvi.67.10.6170-6178.1993 · DOI
  12. Crusius, 1997, Enhancement of EGF- and PMA-mediated MAP kinase activation in cells expressing the human papillomavirus type 16 E5 protein, Oncogene, 15, 1437, 10.1038/sj.onc.1201312 · DOI · Paper page
  13. Crusius, 1998, The human papillomavirus type 16 E5-protein modulates ligand-dependent activation of the EGF receptor family in the human epithelial cell line HaCaT, Exp. Cell Res., 241, 76, 10.1006/excr.1998.4024 · DOI · Paper page
  14. Crusius, 1999, The human papillomavirus type 16 E5 protein modulates phospholipase C-γ-1 and phosphatidylinositol turnover in mouse fibroblasts, Oncogene, 18, 6714, 10.1038/sj.onc.1203075 · DOI
  15. Crusius, 2000, The human papillomavirus type 16 E5 protein modulates ERK1/2 and p38 MAP kinase activation by an EGFR-independent process in stressed human keratinocytes, Virus Genes, 20, 65, 10.1023/A:1008112207824 · DOI · Paper page
  16. Eilers, 2000, Internal packing of helical membrane proteins, Proc. Natl. Acad. Sci. USA, 97, 5796, 10.1073/pnas.97.11.5796 · DOI
  17. Finbow, 1997, The vacuolar H+-ATPase, Biochem. J., 324, 697, 10.1042/bj3240697 · DOI
  18. Goldstein, 1990, The E5 oncoprotein of bovine papillomavirus binds to a 16 kd protein, EMBO J., 9, 137, 10.1002/j.1460-2075.1990.tb08089.x · DOI
  19. Goldstein, 1994, The bovine papillomavirus type 1 E5 transforming protein specifically binds and activates the β-type receptor for the platelet-derived growth factor but not other related tyrosine kinase-containing receptors to induce cellular transformation, J. Virol., 68, 4432, 10.1128/jvi.68.7.4432-4441.1994 · DOI
  20. Gray, 1984, Intrahelical hydrogen bonding of serine, threonine and cysteine residues within alpha-helices and its relevance to membrane-bound proteins, J. Mol. Biol., 175, 75, 10.1016/0022-2836(84)90446-7 · DOI
  21. Gromiha, 1999, A simple method for predicting transmembrane alpha helices with better accuracy, Prot. Eng., 12, 557, 10.1093/protein/12.7.557 · DOI
  22. Gu, 1995, Effect of human papillomavirus type 16 oncogenes on MAP kinase activity, J. Virol., 69, 8051, 10.1128/jvi.69.12.8051-8056.1995 · DOI · Paper page
  23. Hwang, 1995, The HPV16 E5 protein, Virology, 211, 227, 10.1006/viro.1995.1395 · DOI
  24. Kell, 1994, Detection of E5 oncoprotein in human papillomavirus type 16-positive cervical scrapes using antibodies raised to synthetic peptides, J. Gen. Virol., 75, 2451, 10.1099/0022-1317-75-9-2451 · DOI · Paper page
  25. Kulke, 1992, The central hydrophobic domain of the bovine papillomavirus E5 transforming protein can be functionally replaced by many hydrophobic amino acid sequences containing a glutamine, J. Virol., 66, 505, 10.1128/jvi.66.1.505-511.1992 · DOI
  26. Lai, 1998, Bovine papillomavirus E5 protein induces oligomerization and trans-phosphorylation of the platelet-derived growth factor β receptor, Proc. Natl. Acad. Sci. USA, 95, 15241, 10.1073/pnas.95.26.15241 · DOI
  27. Leechanachai, 1992, The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus, Oncogene, 7, 19
  28. Leptak, 1991, Tumorigenic transformation of murine keratinocytes by the E5 genes of bovine papillomavirus type 1 and human papillomavirus type 16, J. Virol., 65, 7078, 10.1128/jvi.65.12.7078-7083.1991 · DOI · Paper page
  29. Martin, 1989, The bovine papillomavirus E5 transforming protein can stimulate the transforming activity of EGF and CSF-1 receptors, Cell, 59, 21, 10.1016/0092-8674(89)90866-0 · DOI
  30. Mattoon, 2001, Identification of the transmembrane dimer interface of the bovine papillomavirus E5 protein, Oncogene, 20, 3824, 10.1038/sj.onc.1204523 · DOI
  31. Mayer, 1998, Temporal and spatial expression of the E5a protein during the differentiation-dependent life cycle of human papillomavirus type 31b, Virology, 248, 208, 10.1006/viro.1998.9262 · DOI
  32. Myers, 1993, Assembly of the peripheral domain of the bovine vacuolar H+-adenosine triphosphatase, J. Cell. Physiol., 156, 35, 10.1002/jcp.1041560106 · DOI
  33. Nelson, 1990, Disruption of genes encoding subunits of yeast vacuolar H+-ATPase causes conditional lethality, Proc. Natl. Acad. Sci. USA, 87, 3507, 10.1073/pnas.87.9.3503 · DOI
  34. Nilson, 1995, Mutational analysis of the interaction between the bovine papillomavirus E5 transforming protein and the endogenous β receptor for platelet-derived growth factor in mouse C127 cells, J. Virol., 69, 5869, 10.1128/jvi.69.9.5869-5874.1995 · DOI
  35. Oelze, 1995, Human papillomavirus type 16 E5 protein affects cell-cell communication in an epithelial cell line, J. Virol., 69, 4489, 10.1128/jvi.69.7.4489-4494.1995 · DOI
  36. Oetke, 2000, Human papillomavirus type 16 E5 protein localizes to the Golgi apparatus but does not grossly affect cellular glycosylation, Arch. Virol., 145, 2183, 10.1007/s007050070048 · DOI
  37. Petti, 1991, Activation of the platelet-derived growth factor receptor by the bovine papillomavirus E5 transforming protein, EMBO J., 10, 845, 10.1002/j.1460-2075.1991.tb08017.x · DOI
  38. Pim, 1992, Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor, Oncogene, 7, 27
  39. Rodriguez, 2000, Binding of human papillomavirus 16 E5 to the 16 kDa subunit c (proteolipid) of the vacuolar H+-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation, Oncogene, 19, 3727, 10.1038/sj.onc.1203718 · DOI
  40. Schapiro, 2000, Golgi alkalinization by the papillomavirus E5 oncoprotein, J. Cell. Biol., 148, 305, 10.1083/jcb.148.2.305 · DOI
  41. Schoonderwoert, 2000, Inhibition of the vacuolar H+-ATPase perturbs the transport, sorting, processing and release of regulated secretory proteins, J. Biochem., 267, 5646
  42. Smith, 1996, Strong hydrogen bonding interactions involving a buried glutamic acid in the transmembrane sequence of the neu/erbB2-receptor, Nat. Struct. Biol., 3, 252, 10.1038/nsb0396-252 · DOI
  43. Sparkowski, 1995, E5 oncoprotein retained in the endoplasmic reticulum/cis Golgi still induces PDGF receptor autophosphorylation but does not transform cells, EMBO J., 14, 3055, 10.1002/j.1460-2075.1995.tb07308.x · DOI
  44. Sparkowski, 1996, E5 oncoprotein transmembrane mutants dissociate fibroblast transforming activity from 16-kilodalton protein binding and platelet-derived growth factor receptor binding and phosphorylation, J. Virol., 70, 2420, 10.1128/jvi.70.4.2420-2430.1996 · DOI
  45. Straight, 1995, The E5 oncoprotein of human papillomavirus type 15 inhibits the acidification of endosomes in human keratinocytes, J. Virol., 69, 3185, 10.1128/jvi.69.5.3185-3192.1995 · DOI
  46. Suprynowicz, 2000, E5 oncoprotein mutants activate phosphoinositide 3-kinase independently of platelet-derived growth factor receptor activation, J. Biol. Chem., 275, 5111, 10.1074/jbc.275.7.5111 · DOI
  47. Surti, 1998, Structural models of the bovine papillomavirus E5 protein, Proteins, 33, 601, 10.1002/(SICI)1097-0134(19981201)33:4<601::AID-PROT12>3.0.CO;2-I · DOI
  48. Ullman, 1994, Hypothetical structure of the membrane-associated E5 oncoprotein of human papillomavirus type 16, Biochem. Soc. Trans., 22, 439S, 10.1042/bst022439s · DOI
  49. Vali, 2001, Bovine papillomavirus oncoprotein E5 affects the arachidonic acid metabolism in cells, Int. J. Biochem. Cell Biol., 33, 227, 10.1016/S1357-2725(01)00015-2 · DOI
  50. Zhou, 2000, Interhelical hydrogen bonding drives strong interactions in membrane proteins, Nat. Struct. Biol., 7, 154, 10.1038/81919 · DOI
  51. Zhou, 2001, Polar residues drive association of polyleucine transmembrane helices, Proc. Natl. Acad. Sci. USA, 98, 2250, 10.1073/pnas.041593698 · DOI

Metadata

Authors
Gieswein, C. E., Sharom, F. J., & Wildeman, A. G.
Venue
Virology
Publisher
Elsevier BV
Published
2003-09
Volume
313
Issue
2
Pages
415-426
ISSN
0042-6822
Cited by
27
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review